Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) FCF Margin (2020 - 2025)

Bio Essence has reported FCF Margin over the past 6 years, most recently at 83.89% for Q4 2025.

  • For Q4 2025, FCF Margin fell 21364.0% year-over-year to 83.89%; the TTM value through Dec 2025 reached 82.72%, down 5118.0%, while the annual FY2025 figure was 82.72%, 11479.0% down from the prior year.
  • FCF Margin for Q4 2025 was 83.89% at Bio Essence, down from 136.68% in the prior quarter.
  • Over five years, FCF Margin peaked at 401.81% in Q4 2023 and troughed at 352.18% in Q2 2021.
  • A 5-year average of 11.23% and a median of 16.44% in 2023 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: tumbled -24123bps in 2021 and later skyrocketed 35367bps in 2023.
  • Year by year, FCF Margin stood at 109.09% in 2021, then surged by 144bps to 48.14% in 2022, then skyrocketed by 735bps to 401.81% in 2023, then fell by -26bps to 297.53% in 2024, then tumbled by -72bps to 83.89% in 2025.
  • Business Quant data shows FCF Margin for BIOE at 83.89% in Q4 2025, 136.68% in Q3 2025, and 64.76% in Q2 2025.